Last updated: June 5, 2023
Sponsor: Chinese PLA General Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Deafness
Hearing Loss
Hearing Impairment
Treatment
cochlear implant
Clinical Study ID
NCT05435612
SSD-2022-01
Ages > 12 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age: 12 years old and above
- Language ability: postlingual deafness, able to cooperate with sentence test in noise
- Normal mental, intelligence and motor development
- Patients who meet the diagnosis of single-sided deafness and asymmetric hearing loss
Exclusion
Exclusion Criteria:
- Cochlear malformation (except large vestibular aqueduct syndrome)
- Retrocochlear lesions
- Incomplete implantation of cochlear implant electrodes
- Non-Chinese Mandarin communication
Study Design
Total Participants: 30
Treatment Group(s): 1
Primary Treatment: cochlear implant
Phase:
Study Start date:
July 05, 2022
Estimated Completion Date:
July 01, 2026
Study Description
Connect with a study center
Chinese PLA General Hospital
Beijing, Beijing 100085
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.